4 results
Petri dish
Alert
Life Science Private Equity Risk
manhattan
Insight
Reality check: US M&A H1 2022
US deal activity saw an annual decrease in H1 of this year, but remains buoyant compared to pre-pandemic standards
US M&A H1 2022
Insight
SPACs are overcoming expectations
After a series of rollercoaster years for the SPAC market, investors and sponsors are finding ways to improve deal integrity
Record breaker: US M&A 2021
Insight
What's next for SPACs?
Dynamics may be changing as the focus shifts to de-SPACs and regulatory scrutiny intensifies